Similar Posts

UK: Demand to reclassify oral EC
January 2024. In the United Kingdom, the Faculty of Sexual and Reproductive Healthcare (FSRH) published a statement calling for the reclassification of oral emergency contraception (EC) from a Pharmacy (P) medicine to General Sales List (GSL), “to enable oral EC to be purchased from general retail outlets, from supermarkets to petrol stations, removing barriers and…
New EC labeling in Europe
The European label for the EC product Norlevo has been updated with two major changes. In keeping with current evidence, the new label now says that LNG EC works by interfering with ovulation, and the language about the possibility that LNG EC might prevent implantation of a fertilized egg has been removed. The second change…
Contraception atlas for Europe released
In February 2017, the European Parliamentary Forum on Population & Development launched the ContraceptionAtlas, a map scoring 45 European countries on access to modern contraception. Included among the examined factors are number of contraceptives available, what sort of information is available online, level of reimbursement, and availability of emergency contraception. According to the atlas, France is number…
UNFPA’s 2021 State of World Population report
April 202. According to UNFPA’s 2021 State of World Population report, published on April 14, nearly half of women in 57 low income countries are denied the right to decide whether to have sex with their partners, use contraception or seek health care. This is the first time a United Nations report focuses on bodily autonomy: the…
France: free EC pills for all women
September 2022. The French Minister of Health, François Braun, announced that emergency contraception pills (ECPs) will be free for all women regardless of their age, in pharmacies and without a prescription. Read more here. ECPs are provided free of cost to women under 18 since 2013; this measure was extended to women up to the…
Survey: 17% of Irish women have used EC
A Behavior and Attitudes survey carried out on behalf of Bayer Healthcare found that in the last two years, approximately 17% of women had accessed EC, with 5% accessing it more than once. Read more about the survey here.
